Figure 2.
Mutational analysis of patients treated in MPD-RC 112 trial. (A) Oncoprint of baseline mutations and (B) mutation frequency of patients enrolled in the study.

Mutational analysis of patients treated in MPD-RC 112 trial. (A) Oncoprint of baseline mutations and (B) mutation frequency of patients enrolled in the study.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal